A Conversation with Munjal & Hemant
Discover the story behind the creation of Hippocratic AI and how a single conversation sparked a transformative journey to revolutionize care. Watch this insightful chat
Business insights and articles written by our team of world-class professionals
Discover the story behind the creation of Hippocratic AI and how a single conversation sparked a transformative journey to revolutionize care. Watch this insightful chat
The 43rd annual JP Morgan Healthcare Conference spotlighted renewed optimism in healthcare and pharma dealmaking alongside a surge in AI-driven collaborations. Investors expect a rebound
Intermountain Health CEO Rob Allen expressed fascination with a groundbreaking AI application developed by Hippocratic AI during an interview at the J.P. Morgan Healthcare conference.
Hippocratic AI has achieved a $1.64 billion valuation following a successful $126 million Series B funding round led by Kleiner Perkins, a renowned venture capital
Hippocratic AI, a healthcare technology startup founded in 2022, is making strides in integrating AI agents into healthcare workflows, focusing on non-diagnostic, patient-facing tasks such
Andreessen Horowitz’s strategic investments continue to shape industries, with notable support for groundbreaking startups like Hippocratic AI. Based in Palo Alto, Hippocratic AI recently raised
Hippocratic AI, a healthcare AI startup, has secured $141 million in a Series B funding round, bringing its valuation to $1.64 billion. Led by Kleiner
Hippocratic AI, a Palo Alto-based generative AI company developing safety-focused large language models (LLMs) for healthcare, has raised $141 million in a Series B funding
Hippocratic AI, a U.S.-based healthcare AI startup, has raised $141 million in a Series B funding round led by Kleiner Perkins, bringing its valuation to